rs144665682

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The ENST00000330817.11(ALG12):​c.631C>T​(p.Arg211Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0068 in 1,614,130 control chromosomes in the GnomAD database, including 123 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. R211R) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0062 ( 12 hom., cov: 33)
Exomes 𝑓: 0.0069 ( 111 hom. )

Consequence

ALG12
ENST00000330817.11 missense

Scores

1
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 2.17
Variant links:
Genes affected
ALG12 (HGNC:19358): (ALG12 alpha-1,6-mannosyltransferase) This gene encodes a member of the glycosyltransferase 22 family. The encoded protein catalyzes the addition of the eighth mannose residue in an alpha-1,6 linkage onto the dolichol-PP-oligosaccharide precursor (dolichol-PP-Man(7)GlcNAc(2)) required for protein glycosylation. Mutations in this gene have been associated with congenital disorder of glycosylation type Ig (CDG-Ig)characterized by abnormal N-glycosylation. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.006156057).
BP6
Variant 22-49909927-G-A is Benign according to our data. Variant chr22-49909927-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 96097.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-49909927-G-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.00616 (938/152370) while in subpopulation EAS AF= 0.0324 (168/5186). AF 95% confidence interval is 0.0284. There are 12 homozygotes in gnomad4. There are 479 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 12 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ALG12NM_024105.4 linkuse as main transcriptc.631C>T p.Arg211Cys missense_variant 5/10 ENST00000330817.11 NP_077010.1
ALG12XM_017028936.2 linkuse as main transcriptc.631C>T p.Arg211Cys missense_variant 5/10 XP_016884425.1
ALG12XM_017028937.2 linkuse as main transcriptc.631C>T p.Arg211Cys missense_variant 5/11 XP_016884426.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ALG12ENST00000330817.11 linkuse as main transcriptc.631C>T p.Arg211Cys missense_variant 5/101 NM_024105.4 ENSP00000333813 P1
ALG12ENST00000492791.1 linkuse as main transcriptc.163C>T p.Arg55Cys missense_variant, NMD_transcript_variant 1/63 ENSP00000417387

Frequencies

GnomAD3 genomes
AF:
0.00614
AC:
935
AN:
152252
Hom.:
12
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00588
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00321
Gnomad ASJ
AF:
0.00518
Gnomad EAS
AF:
0.0323
Gnomad SAS
AF:
0.0312
Gnomad FIN
AF:
0.00132
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00416
Gnomad OTH
AF:
0.00334
GnomAD3 exomes
AF:
0.00904
AC:
2271
AN:
251096
Hom.:
33
AF XY:
0.0101
AC XY:
1368
AN XY:
135784
show subpopulations
Gnomad AFR exome
AF:
0.00468
Gnomad AMR exome
AF:
0.00200
Gnomad ASJ exome
AF:
0.00517
Gnomad EAS exome
AF:
0.0279
Gnomad SAS exome
AF:
0.0319
Gnomad FIN exome
AF:
0.00171
Gnomad NFE exome
AF:
0.00452
Gnomad OTH exome
AF:
0.00588
GnomAD4 exome
AF:
0.00687
AC:
10037
AN:
1461760
Hom.:
111
Cov.:
34
AF XY:
0.00765
AC XY:
5561
AN XY:
727172
show subpopulations
Gnomad4 AFR exome
AF:
0.00609
Gnomad4 AMR exome
AF:
0.00190
Gnomad4 ASJ exome
AF:
0.00497
Gnomad4 EAS exome
AF:
0.0300
Gnomad4 SAS exome
AF:
0.0309
Gnomad4 FIN exome
AF:
0.00191
Gnomad4 NFE exome
AF:
0.00462
Gnomad4 OTH exome
AF:
0.00777
GnomAD4 genome
AF:
0.00616
AC:
938
AN:
152370
Hom.:
12
Cov.:
33
AF XY:
0.00643
AC XY:
479
AN XY:
74510
show subpopulations
Gnomad4 AFR
AF:
0.00594
Gnomad4 AMR
AF:
0.00320
Gnomad4 ASJ
AF:
0.00518
Gnomad4 EAS
AF:
0.0324
Gnomad4 SAS
AF:
0.0313
Gnomad4 FIN
AF:
0.00132
Gnomad4 NFE
AF:
0.00416
Gnomad4 OTH
AF:
0.00331
Alfa
AF:
0.00562
Hom.:
6
Bravo
AF:
0.00545
TwinsUK
AF:
0.00512
AC:
19
ALSPAC
AF:
0.00545
AC:
21
ESP6500AA
AF:
0.00409
AC:
18
ESP6500EA
AF:
0.00442
AC:
38
ExAC
AF:
0.00944
AC:
1146
Asia WGS
AF:
0.0280
AC:
97
AN:
3478
EpiCase
AF:
0.00567
EpiControl
AF:
0.00462

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Likely benign, criteria provided, single submitterclinical testingGeneDxFeb 12, 2022See Variant Classification Assertion Criteria. -
Likely benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
Benign, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsMay 05, 2015- -
Likely benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
ALG12-congenital disorder of glycosylation Benign:2
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jul 30, 2013- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.42
T
BayesDel_noAF
Benign
-0.35
CADD
Benign
15
DANN
Benign
0.92
DEOGEN2
Benign
0.35
T
Eigen
Benign
-0.90
Eigen_PC
Benign
-0.99
FATHMM_MKL
Benign
0.17
N
LIST_S2
Benign
0.61
T
MetaRNN
Benign
0.0062
T
MetaSVM
Benign
-0.98
T
MutationAssessor
Benign
0.80
N
MutationTaster
Benign
1.0
N
PrimateAI
Benign
0.24
T
PROVEAN
Uncertain
-2.8
D
REVEL
Benign
0.24
Sift
Benign
0.17
T
Sift4G
Benign
0.17
T
Polyphen
0.019
B
Vest4
0.19
MVP
0.63
MPC
0.22
ClinPred
0.0095
T
GERP RS
-2.9
Varity_R
0.099
gMVP
0.49

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs144665682; hg19: chr22-50303575; COSMIC: COSV58208071; COSMIC: COSV58208071; API